GROUP 1: Filling the Gap in TB Drug Discovery

• Carl Nathan - Weill Med Coll - The Pipeline Problem (pdf)
• Federico Gomez de las Heras - GSK (pdf)
• Koen Andries - Tibotec (pdf)
• Stewart Cole - Pasteur Institute (pdf)
• Working Group 1 Proposal Details (pdf)
• Working Group 1 Summary (pdf)

Background Materials

• Drug discovery in jeopardy (pdf)
  Pedro Cuatrecasas
• Prospects for new antitubercular drugs (pdf)
  Ken Duncan and Clifton E Barry III
• Antibiotics at the crossroads (pdf)
  Carl Nathan
• Innovative lead discovery strategies for tropical diseases (pdf)
  Solomon Nwaka and Alan Hudson